HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gareth S D Purvis Selected Research

Reperfusion Injury

7/2017Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gareth S D Purvis Research Topics

Disease

6Inflammation (Inflammations)
01/2022 - 01/2018
4Sepsis (Septicemia)
01/2020 - 01/2017
3Obesity
01/2022 - 10/2020
2Proteinuria
01/2021 - 10/2020
2Fatty Liver
01/2021 - 01/2019
2Multiple Organ Failure (MODS)
01/2020 - 01/2018
2Pneumonia (Pneumonitis)
01/2018 - 01/2017
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Neoplasms (Cancer)
01/2022
1Peritonitis
01/2022
1Insulin Resistance
01/2021
1Hypercholesterolemia
01/2021
1Hemorrhagic Shock
01/2018
1Liver Diseases (Liver Disease)
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Wounds and Injuries (Trauma)
01/2018
1Ischemia
07/2017
1Fibrosis (Cirrhosis)
07/2017
1Reperfusion Injury
07/2017
1Acute Kidney Injury (Acute Renal Failure)
07/2017

Drug/Important Bio-Agent (IBA)

4Phosphotransferases (Kinase)IBA
01/2022 - 01/2017
3Annexin A1IBA
01/2022 - 01/2018
3InflammasomesIBA
01/2021 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2017
3ibrutinibIBA
10/2020 - 01/2019
3Agammaglobulinaemia Tyrosine KinaseIBA
10/2020 - 01/2019
3CytokinesIBA
01/2020 - 01/2017
2acalabrutinibIBA
01/2020 - 01/2019
1SugarsIBA
01/2022
1ZymosanIBA
01/2022
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2021
1Pep19-2.5 peptideIBA
01/2021
1Adenosine Monophosphate (AMP)IBA
01/2021
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
10/2020
1Analgesics (Analgesic Drugs)IBA
01/2020
15S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1CholesterolIBA
01/2019
1GlucocorticoidsIBA
01/2019
1LipidsIBA
01/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019
1Streptozocin (Streptozotocin)FDA Link
01/2018
1CathelicidinsIBA
01/2018
1Pep19-4LFIBA
01/2018
1Mitogen-Activated Protein KinasesIBA
01/2018
1Antimicrobial Cationic PeptidesIBA
01/2018
1JNK Mitogen-Activated Protein KinasesIBA
01/2018
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2018
1CreatinineIBA
07/2017
1Transcription Factors (Transcription Factor)IBA
07/2017
1Fibronectins (Fibronectin)IBA
07/2017
1salicylhydroxamic acid (SHAM)IBA
01/2017

Therapy/Procedure

2Ligation
01/2020 - 01/2017
2Punctures
01/2020 - 01/2017
2Resuscitation
01/2020 - 01/2018
2Nephrectomy
07/2017 - 01/2017
1Intravenous Administration
01/2019